Arias-Badia M - Search Results

1

Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus.

Al-Zaher AA, Moreno R, Fajardo CA, Arias-Badia M, Farrera M, de Sostoa J, Rojas LA, Alemany R. Al-Zaher AA, et al. Among authors: arias badia m. Mol Ther Oncolytics. 2018 Jan 31;8:62-70. doi: 10.1016/j.omto.2018.01.003. eCollection 2018 Mar 30. Mol Ther Oncolytics. 2018. PMID: 29888319 Free PMC article.

2

Albumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic delivery.

Rojas LA, Condezo GN, Moreno R, Fajardo CA, Arias-Badia M, San Martín C, Alemany R. Rojas LA, et al. Among authors: arias badia m. J Control Release. 2016 Sep 10;237:78-88. doi: 10.1016/j.jconrel.2016.07.004. Epub 2016 Jul 4. J Control Release. 2016. PMID: 27388756

3

Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy.

Fajardo CA, Guedan S, Rojas LA, Moreno R, Arias-Badia M, de Sostoa J, June CH, Alemany R. Fajardo CA, et al. Among authors: arias badia m. Cancer Res. 2017 Apr 15;77(8):2052-2063. doi: 10.1158/0008-5472.CAN-16-1708. Epub 2017 Jan 31. Cancer Res. 2017. PMID: 28143835

4

Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11.

Mato-Berciano A, Morgado S, Maliandi MV, Farrera-Sal M, Gimenez-Alejandre M, Ginestà MM, Moreno R, Torres-Manjon S, Moreno P, Arias-Badia M, Rojas LA, Capellà G, Alemany R, Cascallo M, Bazan-Peregrino M. Mato-Berciano A, et al. Among authors: arias badia m. J Control Release. 2021 Apr 10;332:517-528. doi: 10.1016/j.jconrel.2021.02.035. Epub 2021 Mar 3. J Control Release. 2021. PMID: 33675877

5

Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity.

Rodríguez-García A, Svensson E, Gil-Hoyos R, Fajardo CA, Rojas LA, Arias-Badia M, Loskog AS, Alemany R. Rodríguez-García A, et al. Among authors: arias badia m. Gene Ther. 2015 Jul;22(7):596-601. doi: 10.1038/gt.2015.41. Epub 2015 May 21. Gene Ther. 2015. PMID: 25994521

6

TCR signaling promotes formation of an STS1-Cbl-b complex with pH-sensitive phosphatase activity that suppresses T cell function in acidic environments.

Tsai YL, Arias-Badia M, Kadlecek TA, Lwin YM, Srinath A, Shah NH, Wang ZE, Barber D, Kuriyan J, Fong L, Weiss A. Tsai YL, et al. Among authors: arias badia m. Immunity. 2023 Dec 12;56(12):2682-2698.e9. doi: 10.1016/j.immuni.2023.11.010. Immunity. 2023. PMID: 38091950

7

Exhausted intratumoral Vδ2^- γδ T cells in human kidney cancer retain effector function.

Rancan C, Arias-Badia M, Dogra P, Chen B, Aran D, Yang H, Luong D, Ilano A, Li J, Chang H, Kwek SS, Zhang L, Lanier LL, Meng MV, Farber DL, Fong L. Rancan C, et al. Among authors: arias badia m. Nat Immunol. 2023 Apr;24(4):612-624. doi: 10.1038/s41590-023-01448-7. Epub 2023 Mar 16. Nat Immunol. 2023. PMID: 36928415 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7 results

Search Page